Degeneration of oligodendroglia in the central nervous system of rats treated with AY9944 or triparanol.
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001369:Axons / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure; D001593:Benzyl Compounds / Q000494:pharmacology; D002467:Cell Nucleus / Q000187:drug effects / Q000648:ultrastructure; D002490:Central Nervous System / Q000187:drug effects* / Q000503:physiopathology; D002531:Cerebellum / Q000187:drug effects / Q000503:physiopathology / Q000648:ultrastructure; D003510:Cyclohexanes / Q000031:analogs & derivatives* / Q000494:pharmacology; D003593:Cytoplasm / Q000187:drug effects / Q000648:ultrastructure; D008744:Methylamines / Q000494:pharmacology; D008854:Microscopy, Electron; D009186:Myelin Sheath / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure; D009410:Nerve Degeneration / Q000187:drug effects*; D009457:Neuroglia / Q000187:drug effects*; D009836:Oligodendroglia / Q000187:drug effects* / Q000502:physiology; D051381:Rats; D013116:Spinal Cord / Q000187:drug effects / Q000503:physiopathology / Q000648:ultrastructure; D014308:Triparanol / Q000494:pharmacology*
D000924:Anticholesteremic Agents; D001593:Benzyl Compounds; D003510:Cyclohexanes; D008744:Methylamines; D014308:Triparanol